Vantage logo

Glaxo’s growth problem

As assurances that all is well fall on deaf ears, should Glaxosmithkline be thinking more radically?

Vantage logo

A beautiful autumn for Covid-19 test makers

Though orthopaedics companies have begun to recover from the second quarter’s horrors, it is clear that the third quarter belongs to the diagnostics specialists.